… To our knowledge, this study is the first phase 2 randomized clinical trial to evaluate dual …
It is important to undertake studies such as this, even though previous research has reported …

… who participated in this study and to the nurses and staff of the Clinical Research Unit at
Georgetown University Medical Center and all staff of the research pharmacy at MedStar …

… current study, HBsAg reduction either preceded or occurred in parallel with the ALT increase.
The temporal profile observed in this study is different from that shown in a phase 3 study …

Introduction Cariprazine is an orally active and potent D 3 and D 2 partial agonist with preferential
binding to D 3 receptors in development for the treatment of schizophrenia and bipolar …

… Forty clinical sites across the United States participated in this multicenter phase 2 randomized
clinical trial. The study adhered to the tenets of the Declaration of Helsinki 11 and was …

… phase 2 study was to determine the efficacy and safety of bimagrumab on body composition
and glycemic control in adult patients with overweight or obesity and type 2 diabetes. …

… In this open-label, phase 2 randomised controlled trial, patients with NSCLC who progressed
on post-platinum chemotherapy were recruited in 61 academic medical centres and …

… A phase 1 trial of GA with HCQ found that all agents were tolerable at full doses. Based on
these findings, we report herein the subsequent randomized phase 2 trial of GA vs GA plus …

… clinical implementation of this combined intervention in a single centre was feasible.We
designed a phase II trial … of conducting a multicentre randomised clinical trial with a complex …

… In conclusion, we report the first placebo-controlled, phase II RCT of high-dose NAC to
prevent CPB-related acute renal dysfunction in high-risk cardiac surgery patients. NAC was no …